Balto Therapeutics, LLC — Form D
Balto Therapeutics, LLC of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2017-10-03. The offering totals $3.4M, of which $3.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2017-10-03
- Form: D
- Accession: 0001717168-17-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $3.4M
- Amount sold: $3.0M
- Remaining: $400K
- Minimum investment: $50K
- Investors: 8
- Date of first sale: 2017-09-29
- Security types: debt
- Revenue range: No Revenues
- SEC file number: 021-295877
Issuer
- Name: Balto Therapeutics, LLC
- CIK: 0001717168
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 450 LEXINGTON AVENUE, 4TH FLOOR, NEW YORK, NY, 10017
- Phone: 646-450-3580
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Courtney E Bond | Director | New York, NY |
| Thomas E Fernandez | Director | New York, NY |
| Courtney E Bond | Executive Officer | New York, NY |
| Thomas E Fernandez | Executive Officer | New York, NY |
| Courtney E Bond | Promoter | New York, NY |
| Thomas E Fernandez | Promoter | New York, NY |
More